BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35979035)

  • 1. The IncRNA SCIRT Promotes the Proliferative, Migratory, and Invasive Properties of Cervical Cancer Cells by Upregulating MMP-2/-9.
    Guan C; Wang B; Dong Q
    J Oncol; 2022; 2022():3448224. PubMed ID: 35979035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB interaction long non-coding RNA inhibits migration, invasion and epithelial-mesenchymal transition of cervical cancer cells through inhibiting NF-κB signaling pathways.
    Wang F; Jiang X; Wang P
    Exp Ther Med; 2020 Aug; 20(2):1039-1047. PubMed ID: 32765657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
    Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The downregulation of LINC00273 inhibits the proliferation, invasion, and migration of ovarian cancer cells
    Shu C; Liu L; Xue J; Fei J; Chen X; Wang J; Yang X; Peng Q; Zhu W
    Ann Transl Med; 2022 Oct; 10(20):1139. PubMed ID: 36388777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-Coding RNA-NEAT1 Promotes Cell Migration and Invasion via Regulating miR-124/NF-κB Pathway in Cervical Cancer.
    Shen X; Zhao W; Zhang Y; Liang B
    Onco Targets Ther; 2020; 13():3265-3276. PubMed ID: 32368085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of lncRNA NEAT1 inhibits the proliferation of human cutaneous squamous cell carcinoma
    Gong Z; Shen G; Huang C; Zhang J; Ji J
    Ann Transl Med; 2022 Jan; 10(2):79. PubMed ID: 35282061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SCIRT absorbs miR-221 to advance the expression of lncRNA GAS5 in oral squamous cell carcinoma to inhibit cancer cell apoptosis.
    Yang L; Yang K; Wang H; Chen Y; Zhao J
    J Oral Pathol Med; 2022 Mar; 51(3):256-262. PubMed ID: 34547134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SCIRT is downregulated in atherosclerosis and suppresses the proliferation of human aortic smooth muscle cells (HAOSMCs) by sponging miR-146a in cytoplasm.
    Gao W; Li R; Yu J; He X; Xu D; Zhong H; Dong W; Cui H
    J Cardiothorac Surg; 2021 Nov; 16(1):324. PubMed ID: 34742341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA SCIRT Promotes HUVEC Angiogenesis via Stabilizing VEGFA mRNA Induced by Hypoxia.
    Gao L; Yang J; Li Y; Liu K; Sun H; Tang J; Xia Z; Zhang L; Hu Z
    Oxid Med Cell Longev; 2022; 2022():9102978. PubMed ID: 35698607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis.
    Wu L; Zhu L; Li Y; Zheng Z; Lin X; Yang C
    Cancer Cell Int; 2020; 20():12. PubMed ID: 31938020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
    Tian Y; Wang YR; Jia SH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7307-7313. PubMed ID: 31539117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of TUG1 promotes cisplatin sensitivity in cervical cancer by activating the MAPK pathway.
    Wei X; Zhou Y; Qiu J; Wang X; Xia Y; Sui L
    J BUON; 2019; 24(3):1020-1026. PubMed ID: 31424656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
    Li CF; Li YC; Wang Y; Sun LB
    Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
    Ye J; Jiao Y
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells.
    Zagorac S; de Giorgio A; Dabrowska A; Kalisz M; Casas-Vila N; Cathcart P; Yiu A; Ottaviani S; Degani N; Lombardo Y; Tweedie A; Nissan T; Vance KW; Ulitsky I; Stebbing J; Castellano L
    Cancer Res; 2021 Feb; 81(3):580-593. PubMed ID: 33172932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.